SEC Filing Summary: Propanc Health Group Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Propanc Health Group Corporation (also referenced as Propanc Biopharma, Inc.) on June 18, 2015, reporting an event that occurred on May 1, 2015. The filing addresses a corporate administrative update regarding the registrant's principal executive offices.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 8.01 (Other Events) and contains no financial statements or performance data.
Material Changes
The only material change reported is the relocation of the Company's principal executive office. The new address is Level 2, 555 Riversdale Road, Cambwerwell, VIC, 3124, Australia. The Company's telephone number was updated to 613 9882 0780.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly an address change notification.
Key Facts for Investor Verification
- Verify the new principal executive office address: Level 2, 555 Riversdale Road, Cambwerwell, VIC, 3124, Australia.
- Confirm the updated contact telephone number: 613 9882 0780.
- Note the discrepancy between the company name in the metadata (Propanc Biopharma, Inc.) and the registrant name in the filing (Propanc Health Group Corporation).
- Confirm that no financial or operational changes were disclosed in this specific filing.